Pfizer Shifts Focus to Cancer Drugs After Decline in Business Post-COVID-19
Pfizer Inc. is shifting its strategic focus from COVID to cancer pharmaceuticals in an effort to ...
Search Result for 'Pfizer'
No Result
In new move, French vaccines company Valneva to divest 8.1 percent stake to Pfizer
Valneva, a specialty vaccine company, and Pfizer Inc announced that they have entered into an Equity ...
CDC approves low dose Pfizer vaccines for 5–11-year-olds in the US
Advisors to the U.S. Centers for Disease Control and Prevention (CDC) unanimously voted for a low-dose ...
Pfizer – The third booster vaccine of 🦠 COVID-19 combats reduced protection
The Health Ministry of Israel reported conclusions of advancement in the protection against COVID-19 infection, owing ...
Trump’s Order on US Drugs Might Increase Global Drug Prices
When the US compared its prices with other countries, it was two to four times more ...
GSK Strikes A Deal To Pay $2.2 Billion Over Zantac Cancer Claims
GSK states that the drug which is currently selling under the name Zantac 360 now uses ...
Nobel Prizes 2023: Celebrating Human Achievements Driving Technological Advancements
The Nobel Prizes for 2023 were awarded in a ceremony in Oslo, honouring outstanding contributions across ...
BioNTech acquires GMP manufacturing site to establish new mRNA vaccine facility in Singapore
BioNTech’s Singapore facility will create regional manufacturing capacities that will support BioNTech’s growing pipeline of mRNA-based ...
WTO approves new vaccine-patent waiver to help combat Covid Pandemic: June 2022
After an effort of almost two years, involving scores of high-level meetings and much political pressure ...
Moderna’s third dose of COVID19 vaccine to combat against the omicron variant
Moderna stocks surged 1.1% at 10:16 AM on the New York Stock Exchange
The Global Economics Limited is a UK based financial publication and a Bi-Monthly business magazine giving thoughtful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.
